TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biozone Scientific Scandinavia AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
5,090
|
5,161
|
5,338 |
Financial expenses |
15
|
29
|
18 |
Earnings before taxes |
34
|
104
|
-66 |
EBITDA |
22
|
123
|
-50 |
Total assets |
1,096
|
1,622
|
1,974 |
Current assets |
1,096
|
1,622
|
1,974 |
Current liabilities |
371
|
712
|
858 |
Equity capital |
725
|
910
|
1,116 |
- share capital |
101
|
95
|
98 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
66.1%
|
56.1%
|
56.5% |
Turnover per employee |
2,545
|
2,580
|
2,669 |
Profit as a percentage of turnover |
0.7%
|
2.0%
|
-1.2% |
Return on assets (ROA) |
4.5%
|
8.2%
|
-2.4% |
Current ratio |
295.4%
|
227.8%
|
230.1% |
Return on equity (ROE) |
4.7%
|
11.4%
|
-5.9% |
Change turnover |
-437
|
-17
|
-1,580 |
Change turnover % |
-8%
|
0%
|
-23% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.